SCHEMBL5370368

SCHEMBL5370368

O=C(CCCNC(=O)OCC1c2ccccc2-c2ccccc21)ON1C(=O)CCC1=O

nearest known ligand 0.59

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.59
▸ EPHX2 P34913 1/20 0.42
▸ TLR2 O60603 3/20 0.39
▸ TLR1 Q15399 1/20 0.39
▸ OPRD1 P41143 1/20 0.39
▸ TPSAB1 Q15661 1/20 0.39
▸ TPSD1 Q9BZJ3 1/20 0.39
▸ TPSG1 Q9NRR2 1/20 0.39
▸ CASP3 P42574 2/20 0.38
▸ XIAP P98170 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30532195 0.96 KMT2A (0.66) KMT2AEPHX2TLR2TLR1OPRD1
SCHEMBL30532196 0.96 KMT2A (0.66) KMT2AEPHX2TLR2TLR1OPRD1
SCHEMBL84331 0.96 KMT2A (0.66) KMT2AEPHX2TLR2TLR1OPRD1
SCHEMBL20529972 0.96 KMT2A (0.66) KMT2AEPHX2TLR2TLR1OPRD1
SCHEMBL31603929 0.94 KMT2A (0.56) KMT2AEPHX2TLR2TLR1OPRD1
SCHEMBL30905361 0.94 KMT2A (0.56) KMT2AEPHX2TLR2TLR1OPRD1
SCHEMBL15692103 0.94 KMT2A (0.56) KMT2AEPHX2TLR2TLR1OPRD1
SCHEMBL31310023 0.89 KMT2A (0.51) KMT2AEPHX2TLR2TLR1OPRD1
SCHEMBL83644 0.89 KMT2A (0.51) KMT2AEPHX2TLR2TLR1OPRD1
SCHEMBL31309796 0.89 KMT2A (0.51) KMT2AEPHX2TLR2TLR1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 — — US disclosed
US-20170073468-A1 METHOD FOR PREPARING FUNCTIONALIZED POLYMERS FROM POLYMER ALCOHOLS NEKTAR THERAPEUTICS 2017-03-16 — — US disclosed
US-20140073802-A1 MALEIMIDYL POLYMER DERIVATIVES NEKTAR THERAPEUTICS (US) 2014-03-13 — — US disclosed
US-RE39606-E1 Methods and apparatus for synthesizing labeled combinatorial chemistry libraries NEXUS BIOSYSTEMS, INC. (US) 2007-05-01 — — US disclosed
US-RE39571-E1 Methods and apparatus for synthesizing labeled combinatorial chemistry libraries NEXUS BIOSYSTEMS, INC. (US) 2007-04-17 — — US disclosed
US-RE39545-E1 Methods and apparatus for synthesizing labeled combinatorial chemistry libraries NEXUS BIOSYSTEMS, INC. (US) 2007-04-03 — — US disclosed
US-6417010-B1 SYNTHESIS SUPPORT WITH LABEL DISCOVERY PARTNERS INTERNATIONAL 2002-07-09 — — US disclosed
US-6087186-A SYNTHETIC LIBRARY OF RANDOM OLIGOMERS, EACH MEMBER COMPRISING AN OLIGOMER LINKED TO A MICROCHIP ENCODED WITH INFORMATION IDENTIFYING STRUCTURE OF OLIGOMER; FOR DRUG SCREENING IRORI (US) 2000-07-11 — — US disclosed
US-5770455-A IDENTIFIER TAG WHICH IS A MICROCHIP THAT IS PRE-ENCODED OR ENCODABLE WITH INFORMATION THAT IS RELATED BACK TO A DETECTOR WHEN THE TAG IS PULSED WITH ELECTROMAGNETIC RADIATION ONTOGEN CORPORATION (US) 1998-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR KMT2A 3040/4885EPHX2 2665/4885TLR2 2228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback